These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 2481150

  • 1. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
    Kawahara H, Marceau N, French SW.
    Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice.
    Cadrin M, Anderson NM, Aasheim LH, Kawahara H, Franks DJ, French SW.
    Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study.
    Okanoue T, Ohta M, Ou O, Kachi K, Kagawa K, Yuki T, Okuno T, Takino T, French SW.
    Lab Invest; 1985 Nov; 53(5):534-40. PubMed ID: 2414564
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies.
    Preisegger KH, Zatloukal K, Spurej G, Denk H.
    Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice.
    Irie T, Benson NC, French SW.
    Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products.
    Preisegger KH, Stumptner C, Riegelnegg D, Brown PC, Silverman JA, Thorgeirsson SS, Denk H.
    Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270
    [Abstract] [Full Text] [Related]

  • 14. Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice.
    Cadrin M, Marceau N, French SW.
    J Hepatol; 1992 Mar; 14(2-3):226-31. PubMed ID: 1380022
    [Abstract] [Full Text] [Related]

  • 15. The Mallory body as an aggresome: in vitro studies.
    Riley NE, Li J, Worrall S, Rothnagel JA, Swagell C, van Leeuwen FW, French SW.
    Exp Mol Pathol; 2002 Feb; 72(1):17-23. PubMed ID: 11784119
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mallory bodies compared with microfilament hyperplasia.
    Sim JS, Franks KE, French SW, Caldwell MG.
    Arch Pathol Lab Med; 1977 Aug; 101(8):401-4. PubMed ID: 195552
    [Abstract] [Full Text] [Related]

  • 19. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation.
    Bardag-Gorce F, Riley NE, Nan L, Montgomery RO, Li J, French BA, Lue YH, French SW.
    Exp Mol Pathol; 2004 Feb; 76(1):9-16. PubMed ID: 14738863
    [Abstract] [Full Text] [Related]

  • 20. On the three-dimensional structure of quick-frozen hepatic Mallory bodies with special reference to the appearance of cytoplasmic vesicles.
    Irie T, Koyama W, Ikeuchi Y, Kanaseki T.
    Cell Struct Funct; 1991 Feb; 16(1):1-16. PubMed ID: 1709594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.